VEGFA and Blindness: Recent studies on the pathogenesis of nAMD and DME indicated anti-vascular endothelial growth factor (VEGF) played a vital role in preventing blindness, and VEGF inhibitors served as the first-line standard-of-care for patients with nAMD, DME, and pmCNV (VEGF, 2015).